Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance

Cells. 2022 Jun 5;11(11):1851. doi: 10.3390/cells11111851.

Abstract

Background: Fecal microbiota transplantation (FMT) may contribute to disease remission in ulcerative colitis (UC). We studied the microbiota change and its regulation on T cells after FMT. Methods: Patients with mild to moderately active UC were included to receive FMT. The intestinal histopathological changes and barrier function were evaluated. The fecal samples of donors and patients were analyzed by 16S rRNA gene-based microbiota analysis, and the colon Th17 and Treg cells were assessed. Results: Fifteen patients completed the 8-week-follow-up. A total of 10 patients (66.7%) were in the responders (RE) group and five in the non-responders (NR) group. The Nancy histological index and fecal calprotectin decreased (p < 0.001, p = 0.06, respectively) and Occludin and Claudin1 increased in the RE group. The abundance of Faecalibaterium increased significantly by 2.3-fold in the RE group at week 8 (p = 0.043), but it was suppressed in the NR group. Fecal calprotectin (r = −0.382, p = 0.003) and Nancy index (r = −0.497, p = 0.006) were correlated inversely with the abundance of Faecalibacterium, respectively. In the RE group the relative mRNA expression of RORγt decreased and Foxp3 increased. Significantly decreased CD4+ RORγt+ Th17 and increased CD4+ Foxp3+ Treg were also observed in the RE group. The relative abundance of Faecalibacterium correlated with CD4+ RORγt+ Th17 (r = −0.430, p = 0.018) and CD4+ Foxp3+ Treg (r = 0.571, p = 0.001). Conclusions: The long-term Faecalibaterium colonization following FMT plays a crucial role in UC remission by alleviating intestinal inflammation. This anti-inflammatory effect of Faecalibacterium may be achieved by regulating the imbalance of Th17/Treg levels in UC.

Keywords: T cell; fecal microbiota transplantation; ulcerative colitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colitis, Ulcerative* / pathology
  • Fecal Microbiota Transplantation
  • Forkhead Transcription Factors
  • Gastrointestinal Microbiome*
  • Humans
  • Leukocyte L1 Antigen Complex / pharmacology
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / genetics
  • RNA, Ribosomal, 16S
  • T-Lymphocytes, Regulatory / pathology
  • Transcription Factors*

Substances

  • Forkhead Transcription Factors
  • Leukocyte L1 Antigen Complex
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • RNA, Ribosomal, 16S
  • Transcription Factors
  • negative elongation factor

Grants and funding

This study was funded by the Clinical Research Cultivating Program of the Shanghai Hospital Development Center (SHDC12017X09); the Foundation of Shanghai Jiao Tong University School of Medicine for the Research-oriented Doctors (No. 20181813); the Clinical Research Plan of the Shanghai Hospital Development Center (SHDC2020CR2014A) and the National Natural Science Foundation of China (No. 81970555).